Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer

Nature Medicine volume 2, pages 461–462 (1996)Cite this article

Abstract

Colorectal cancer is one of the commonest malignant tumors and has a relatively poor prognosis. The outcome depends on the extent of local and particularly metastatic tumor spread. The matrix metalloproteinases (MMPs) are a family of closely related enzymes that degrade the extracellular matrix and are considered to be important in facilitating tumor invasion and spread1–3. Using immunohistochemistry we have investigated the occurrence in colorectal cancer of MMP–1 (interstitial collagenase). Our monoclonal antibody was prepared against a synthetic peptide corresponding to an amino acid sequence specific for MMP–1 and was selected to react in formalin–fixed wax–embedded sections, thus allowing use in diagnostic histopathology and also enabling access to archival material. We found that the presence of MMP–1 in colorectal cancer is associated with a poor prognosis (P = 0.006) and has prognostic value independent of Dukes stage. One MMP inhibitor that strongly inhibits MMP–1 has already been shown to inhibit growth of human colon cancer xenografts in nude mice4. Our results suggest that treatment of those individuals whose colon tumors produce MMP–1 with MMP inhibitors is a therapeutic strategy worth pursuing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Hart, I.R. & Saini, A. Biology of tumour metastasis. Lancet 339, 1453–1457 (1992).

    Article  CAS  Google Scholar 

  2. Liotta, L.A., Steeg, P.S. & Stetler-Stevenson, W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64, 327–336 (1991).

    Article  CAS  Google Scholar 

  3. Stetler-Stevenson, W.G., Liotta, L.A. & Kleiner, D.E. Extracellular matrix 6: Role of matrix metalloproteinases in tumour invasion and metastasis. FASEB J. 7, 1434–1441 (1992).

    Article  Google Scholar 

  4. Wang, X., Fu, X., Brown, P.D., Crimmin, M.J. & Hoffman, R.M., Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumour growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54, 4726–4728 (1994).

    CAS  PubMed  Google Scholar 

  5. Duncan, M.E., McAleese, S.M., Booth, N.A., Melvin, W.T. & Fothergill, J.E. A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences. J. Immunol Meth. 151, 227–236 (1992).

    Article  CAS  Google Scholar 

  6. Van Der Stappen, J.W.J., Hendriks, T. & Wobbes, T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int. J. Cancer 45, 1071–1078 (1990).

    Article  CAS  Google Scholar 

  7. Irimura, T., Yamori, T., Bennett, S.C., Ota, D.M. & Cleary, K.R. The relationship of collagenase activity to stage of human colorectal tumours. Int. J. Cancer 40, 24–31 (1987).

    Article  CAS  Google Scholar 

  8. Hewitt, R.E. et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int. J. Cancer 49, 666–672 (1991).

    Article  CAS  Google Scholar 

  9. Gray, S.T., Yun, K., Motoori, T. & Kuys, Y.M. Interstitial collagenase gene expression in colonic neoplasia. Am. J. Pathol. 143, 663–671 (1993).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Urbanski, S.J., Edwards, D.R., Hershfield, N., Huchcroft, S.A., Shaffer, E., Sutherland, L. & Kossakowska, A.E. Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn. Mol. Pathol 2, 81–89 (1993).

    Article  CAS  Google Scholar 

  11. Fenoglio-Preiser, C.M. & Noffsinger, A.E. Epithelial tumours and tumour-like conditions. in Gastro-intestinal and Oesophageal Pathology (ed. Whitehead, R.) 863–892 (Churchill Livingstone, Edinburgh, 1995).

    Google Scholar 

  12. Brown, P.D. Matrix metalloproteinase inhibitors: A new class of anticancer agent. Curr. Opin. Invest. Drug 2, 617–626 (1993).

    Google Scholar 

  13. Murray, G.I., Duncan, M.E., Melvin, W.T. & Fothergill, J.E. Immunohistochemistry of neuron specific enolase with gamma-subunit specific anti-peptide monoclonal antibodies. J. Clin. Pathol. 46, 993–996 (1993).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Aberdeen, Aberdeen, AB9 2ZD, UK

    Graeme I. Murray & Pauline O'Neil

  2. Department of Molecular & Cell Biology, University of Aberdeen, Aberdeen, AB9 2ZD, UK

    Margaret E. Duncan, William T. Melvin & John E. Fothergill

Authors
  1. Graeme I. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret E. Duncan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pauline O'Neil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. William T. Melvin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John E. Fothergill
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murray, G., Duncan, M., O'Neil, P. et al. Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer. Nat Med 2, 461–462 (1996). https://doi.org/10.1038/nm0496-461

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0496-461

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing